Trials
Search / Trial NCT05658549

Effect of N-Acetylcysteine on Neutrophil Lymphocyte Ratio And Length of Stay In COVID-19 Patients

Launched by UNIVERSITAS SEBELAS MARET · Dec 17, 2022

Trial Information

Current as of January 22, 2025

Completed

Keywords

ClinConnect Summary

This research was an observational analytic cohort retrospective study in which the subjects were moderate degree COVID-19 inpatients in Sebelas Maret University Hospital divided into four groups. The control group K0 received standard therapy without NAC, while the treatment group K1 received NAC injections of 1200mg/day, K2 NAC tablets 3x400mg/day, and K3 NAC tablets 3x200mg/day. Different tests using Way ANOVA and LSD or Kruskal-Wallis and Mann-Whitney.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • moderate or severe grade confirmed COVID-19 (patients with symptoms and radiological examination showing pneumonia with or without signs of severe pneumonia: SpO2\<90%, respiratory rate\>30x/min, and severe respiratory distress) who were admitted to UNS Hospital and age 18-60 years old
  • Exclusion Criteria:
  • patients who died during the treatment period

About Universitas Sebelas Maret

Universitas Sebelas Maret (UNS) is a prominent educational institution in Indonesia, committed to advancing research and innovation in various fields, including health sciences. With a strong emphasis on clinical research, UNS strives to enhance medical knowledge and improve patient care through rigorous scientific investigation. The university collaborates with multiple stakeholders, including healthcare providers and governmental bodies, to conduct clinical trials that adhere to ethical standards and contribute to global health advancements. UNS is dedicated to fostering a culture of excellence in research, training future healthcare professionals, and addressing pressing health challenges in the community and beyond.

Locations

Sukoharjo, Central Java, Indonesia

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials